First-in-Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer.

Saved in:
Bibliographic Details
Title: First-in-Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer.
Authors: He AR; Department of Medicine, Georgetown University Medical Center, Washington, DC, USA arh29@georgetown.edu., Cohen RB; Perelman School of Medicine at the University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania, USA., Denlinger CS; Department of Hematology/Oncology, Fox Chase Cancer Center, Temple Health, Philadelphia, Pennsylvania, USA., Sama A; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Birnbaum A; Division of Hematology/Oncology, Rhode Island Hospital, Providence, Rhode Island, USA., Hwang J; Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina, USA., Sato T; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Lewis N; Translational Clinical Oncology, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Mynderse M; Syneos Health, Raleigh, North Carolina, USA., Niland M; Eli Lilly and Company, Indianapolis, Indiana, USA., Giles J; Eli Lilly and Company, Indianapolis, Indiana, USA., Wallin J; Eli Lilly and Company, Stockholm, Sweden., Moser B; Eli Lilly and Company, Indianapolis, Indiana, USA., Zhang W; Eli Lilly and Company, Indianapolis, Indiana, USA., Walgren R; Eli Lilly and Company, Indianapolis, Indiana, USA., Plimack ER; Department of Hematology/Oncology, Fox Chase Cancer Center, Temple Health, Philadelphia, Pennsylvania, USA.
Source: The oncologist [Oncologist] 2019 Sep; Vol. 24 (9), pp. e930-e942. Date of Electronic Publication: 2019 Mar 04.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1549-490X
DOI:10.1634/theoncologist.2018-0411